France PECAN Digital Therapeutics and Telemonitoring Market Research Report – Segmented by Therapeutic Area (Diabetes Management, Cardiovascular Disease Management, Respiratory Disease Management, Oncology Support & Symptom Monitoring, Neurology & Mental Health Management, Others); by Monitoring Modality (Remote Physiological Monitoring, Therapeutic Adherence Monitoring, Connected Medical Device-Based Monitoring, Patient-Reported Outcome Monitoring, AI-Enabled Predictive Monitoring, Others); by Care Setting (Hospital-Based Care, Ambulatory & Outpatient Care, Primary Care Networks, Home-Based Care, Long-Term Care & Rehabilitation Facilities, Others); by Technology Platform (Mobile Application-Based Platforms, Web-Based Clinical Platforms, Connected Wearables Platforms, Medical Device-Integrated Platforms, Cloud-Based Care Management Platforms, Others); by Reimbursement & Funding Model (PECAN Reimbursed Solutions, National Health Insurance-Funded Programs, Hospital-Funded Deployments, Regional Health Authority-Funded Programs, Private Insurance-Supported Programs, Others) ; and Region - Size, Share, Growth Analysis | Forecast (2026– 2030)

The France PECAN Digital Therapeutics and Telemonitoring Market was valued at approximately USD 312 Million. It is projected to grow at a CAGR of around 15.7% during the forecast period of 2026–2030, reaching an estimated USD 646.88 Million by 2030.

The major drivers of the France PECAN Digital Therapeutics and Telemonitoring Market include the growing focus on digitally supported chronic care pathways, increasing adoption of connected monitoring technologies, and strengthening reimbursement frameworks for digital healthcare solutions. Healthcare providers are increasingly leveraging digital therapeutics and telemonitoring platforms to improve patient engagement, automate routine follow-ups, enhance care coordination, and support continuous disease management beyond traditional healthExchange Use Case s. Additionally, the expansion of reimbursement mechanisms and the growing emphasis on operational efficiency, proactive patient monitoring, and scalable healthcare delivery models continue to accelerate market growth across France.

Diabetes Management, Cardiovascular Disease Management, Respiratory Disease Management, Oncology Support & Symptom Monitoring, Neurology & Mental Health Management, and Others are the segments under the France PECAN Digital Therapeutics and Telemonitoring Market by Therapeutic Area. Remote Physiological Monitoring, Therapeutic Adherence Monitoring, Connected Medical Device-Based Monitoring, Patient-Reported Outcome Monitoring, AI-Enabled Predictive Monitoring, and Others are the segments by Monitoring Modality. Hospital-Based Care, Ambulatory & Outpatient Care, Primary Care Networks, Home-Based Care, Long-Term Care & Rehabilitation Facilities, and Others are the segments by Exchange Use Case . Mobile Application-Based Platforms, Web-Based Clinical Platforms, Connected Wearables Platforms, Medical Device-Integrated Platforms, Cloud-Based Care Management Platforms, and Others are the segments by Technology Platform. PECAN Reimbursed Solutions, National Health Insurance-Funded Programs, Hospital-Funded Deployments, Regional Health Authority-Funded Programs, Private Insurance-Supported Programs, and Others are the segments by Reimbursement & Funding Model. Île-de-France, Auvergne-Rhône-Alpes, Provence-Alpes-Côte d’Azur, Occitanie, and Remaining France are the regional segments under the France PECAN Digital Therapeutics and Telemonitoring Market.

Île-de-France is the most dominant region in the France PECAN Digital Therapeutics and Telemonitoring Market, supported by its advanced healthcare infrastructure, strong concentration of digital health innovators, extensive healthcare provider networks, and high adoption of telemonitoring and digital therapeutic solutions. Occitanie is expected to be the fastest-growing region during the forecast period of 2026–2030, driven by expanding healthcare digitization initiatives, growing investments in remote care infrastructure, and increasing deployment of chronic disease management programs. Auvergne-Rhône-Alpes, Provence-Alpes-Côte d’Azur, and Remaining France continue to experience steady growth due to ongoing modernization of healthcare delivery and increasing utilization of connected care technologies.

The key players in the France PECAN Digital Therapeutics and Telemonitoring Market include Cureety, Diabeloop, Voluntis, Doctolib, Withings, BioSerenity, Implicity, Wefight, Resilience (Resilience Care), Cegedim Health Data, Sanofi, Air Liquide Healthcare, Philips France, Medtronic France, and Minze Health.